跳至主要内容
临床试验/IRCT201512315280N22
IRCT201512315280N22已完成未知

Efficacy and Safety of Augmenting Autologous Bone Marrow Stem Cell Therapy in Routine Treatment of Children with Autism Spectrum Disorder: A Randomized Clinical Trial

Mashhad University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 15 years(—)
性别
All

入选标准

  • age range of =5 and =15 years
  • a definite diagnosis of ASD based on DSM

排除标准

  • a long history of allergic reactions
  • seizures during the past six months
  • brain trauma
  • moderate to severe extrapyramidal symptoms and tardive dyskinesia
  • severe self-injury behavior
  • autoimmune diseases
  • severe hematologic and pulmonary disease (such as pneumonia, asthma, malignancy and immune deficiency)
  • severe focal or systemic infection (such as AIDS, hepatitis and syphilis)
  • kidney and liver problems
  • anemia and hemoglobin level less than 8 g/dL
  • bone marrow- associated diseases
  • receiving other treatments affecting the health of stem cell therapy

研究者

相似试验